brusatol has been researched along with Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Z; Han, C; Jiang, Y; Li, N; Li, X; Lin, J; Lv, P; Tong, L; Wang, Y; Zhang, L | 1 |
| Bartsch, JW; Bian, C; Guo, Y; Huang, X; Ji, P; Jiang, X; Li, W; Nisar, MF; Shi, G; Wang, M; Wu, Y; Zhong, JL | 1 |
2 other study(ies) available for brusatol and Melanoma
| Article | Year |
|---|---|
HOXB9 a miR-122-5p regulated gene, suppressed the anticancer effects of brusatol by upregulating SCD1 expression in melanoma.
Topics: Cell Line, Tumor; Gene Expression Regulation; Homeodomain Proteins; Humans; Melanoma; MicroRNAs; Quassins; Stearoyl-CoA Desaturase | 2023 |
UVA Irradiation Enhances Brusatol-Mediated Inhibition of Melanoma Growth by Downregulation of the Nrf2-Mediated Antioxidant Response.
Topics: Animals; Antioxidants; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Radiation; Down-Regulation; Gene Knockout Techniques; Humans; Inactivation, Metabolic; Melanoma; Mice, Nude; NF-E2-Related Factor 2; Proto-Oncogene Proteins c-akt; Quassins; Reactive Oxygen Species; Signal Transduction; Ultraviolet Rays | 2018 |